Digital Transformation

This evolution of healthcare involves using technology to improve diagnosis, treatments, monitor patients, enhance hospital operations and culture, and bolster consumer-focused care. This includes virtual reality tools, wearable devices, workflow software, health apps and other digital health tools.

From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Healthcare AI regulation needs nuance, balance: Research review
When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.
ICU diary-keeping: There’s an AI for that
Intensive care units around the world use daily diaries to track patients’ emotional as well as physical ups and downs. Many find that keeping these helpful resources can add to nurses’ already-heavy workloads. How might generative AI help?
Stanford HAI lookback: Best-read blog posts of 2024
The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.
Providers, payers share actionable experiences involving healthcare AI
A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

23andMe, Genetech enter $50M deal

Pharmaceutical company Genetech is expected to pay as much as $50 million to 23andMe to access its genetic data donated by consumers, reports The Verge.

January 9, 2015

IBM, Epic make preparations for DoD EHR work

The Department of Defense has yet to choose which bidder will take on its $11 EHR billion contract, but that has not stopped IBM and Epic from beginning preparations on their collaborative effort to overhaul the system, reports FCW.

January 8, 2015

Moving closer to MU Stage 3

Big news on the Meaningful Use Stage 3 front: The proposed rule has been sent to the Office of Management and Budget and will be published in the Federal Register upon review, reports Clinical Innovation + Technology.

January 7, 2015

Politico: States fail to track Medicaid EHR payments

The vast majority of states and the federal government fail to track how many Medicaid physicians use EHRs, reports Politico. 

December 23, 2014

Apple to enhance health apps

Apple iOS 8/2, which was released in beta form to developers last week, contains notes indicating that blood glucose tracking will be included as a feature, reports Forbes.

December 23, 2014

Privacy concerns raised over wellness programs

The recent hack of Sony Corp. is bringing to light how much electronic health data proliferates outside of the medical setting, according to Bloomberg.  

December 18, 2014

Microsoft, Health Catalyst collaborate on health analytics

Health Catalyst, a Utah-based data warehousing and analytics company, is partnering with Microsoft to deploy data warehouse and analytics solutions for the healthcare sector, according to Clinical Innovation + Technology.

December 16, 2014

Wearables: Where reality meets hype

Developers of wearable technology have had their fair share of reality checks recently, reports Forbes.

December 10, 2014

Around the web

Cardiovascular Business

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare

From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.

Cardiovascular Business

Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.